Fundraising FoxMIRA DX, Inc.
1 known investors
Find your way into MIRA DX, Inc.
Sign up to find every way you can get introduced to MIRA DX, Inc.
- Your email: who you already know at MIRA DX, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MIRA DX, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.
Founders & leadership
JW
Joanne WeidhaasCo-founder
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MIRA DX, Inc. do?
- MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.
- Who founded MIRA DX, Inc.?
- MIRA DX, Inc. was founded by Joanne Weidhaas.
- Who are MIRA DX, Inc.'s investors?
- MIRA DX, Inc.'s investors include Westway Capital.